Steris
Prix: 207.56Entreprise et modèle économique
Steris is a healthcare company specializing in infection prevention, surgical and critical care products, and laboratory services. Its core offerings include sterilization systems, surgical instruments, and endoscopy products. Major business segments encompass Healthcare Products, Healthcare Services, and Life Sciences. The primary revenue sources are derived from the sale of medical devices and services aimed at enhancing patient safety and operational efficiency in healthcare settings.
Profil d’investissement
The investment profile of Steris indicates a focus on stability rather than aggressive growth, appealing more to value and balanced investors. The company offers a modest dividend yield, suggesting some income potential, but the elevated risk factors may deter conservative investors. The stock's performance is characterized by moderate volatility, making it suitable for those with a medium to long-term investment horizon.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 7.95 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- 6.2% ↑
- Surprise BPA
- -1.0% conforme
- Volatilité 20 j
- 1.1% stable
- Rendement du dividende
- 1.2% modéré dernière date ex-dividende: 2026-06-08
Suivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-09 02:52 | Conserver | Vendre | Weak momentum and high risk limit upside potential. |
| 2026-06-01 02:51 | Vendre | Conserver | Weak momentum and high risk overshadow potential upside. |
| 2026-05-08 15:08 | — | Vendre | Weak momentum and high risk; hold for now. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-05-21 12:59 | Piper Sandler | Mettre à jour | — → 270 | 216.175 |
| 2026-05-13 10:37 | KeyBanc | Objectif abaissé | 291 → 269 | 210.85 |
Rien pour le moment